|1.||Jankovic, Joseph: 15 articles (04/2013 - 11/2002)|
|2.||Ondo, William G: 8 articles (08/2012 - 11/2002)|
|3.||Frank, Samuel: 6 articles (01/2014 - 05/2008)|
|4.||Hunter, Christine: 6 articles (02/2013 - 01/2007)|
|5.||Davidson, Anthony: 4 articles (02/2013 - 01/2007)|
|6.||Shoulson, Ira: 3 articles (01/2013 - 05/2008)|
|7.||Clarence-Smith, Kathleen: 3 articles (01/2013 - 01/2011)|
|8.||Kenney, Christopher: 3 articles (01/2007 - 01/2006)|
|9.||Yohn, Samantha E: 2 articles (02/2016 - 08/2015)|
|10.||Podurgiel, Samantha J: 2 articles (02/2016 - 08/2015)|
|1.||Chorea (Rheumatic Chorea)
12/01/2011 - "The antichorea efficacy of tetrabenazine was maintained in an 80-week extension study (n = 75), with the adjusted mean UHDRS total maximum chorea score significantly (p < 0.001) reduced from baseline (score of 14.9) by 4.6 points (primary outcome). "
03/01/2015 - "On the basis of some research evidence and clinical experience, tetrabenazine may be effective in treating chorea. "
01/01/2012 - "This pilot study demonstrates tetrabenazine's potential effects beyond improvement in chorea."
01/01/2013 - "Tetrabenazine treatment was associated with long-term improvement in chorea. "
01/01/2013 - "Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases."
|2.||Movement Disorders (Movement Disorder)
06/30/1979 - "Tetrabenazine produced moderate to marked improvement in the movement disorder in 79% of a series of 40 Australian patients. "
04/01/2011 - "Small trials indicate tetrabenazine may be effective for the treatment of tardive dyskinesia. "
04/01/1985 - "Although tetrabenazine masked symptoms in 5 of 7 patients to whom it was administered, none was able to achieve remission of tardive dyskinesia when taken off the drug. "
05/01/2013 - "As might be anticipated from its pharmacological profile, tetrabenazine has the potential to cause tardive dyskinesia. "
05/01/2013 - "Tardive dyskinesia caused by tetrabenazine."
04/01/1972 - "Tetrabenazine is an effective agent for the suppression of choreiform and ballistic involuntary movements. "
05/01/2013 - "Generalized choreiform dyskinesia developed after 10 months of conventional-dosage tetrabenazine treatment, persisting for several weeks after the drug was discontinued. "
01/01/2012 - "Dual treatment of hemichorea-hemiballismus syndrome with tetrabenazine and chemodenervation."
08/01/2009 - "Pelvic dyskinesia with an outstanding response to tetrabenazine."
07/01/2009 - "In one, abnormal movements persisted despite treatment with tetrabenazine. "
01/01/2008 - "In clinical studies, tetrabenazine has been found to be effective in a wide range of hyperkinetic movement disorders, including small numbers (<50) of patients with TS in some studies. "
01/01/1982 - "In a double-blind crossover trial of tetrabenazine versus placebo, 19 patients with a variety of hyperkinetic movement disorders were evaluated. "
04/01/2014 - "We assessed and characterized these hyperkinetic movements in detail and investigated the effect of tetrabenazine (TBZ) treatment. "
11/01/2013 - "VMAT2 is also a target of tetrabenazine, a drug used in the treatment of hyperkinetic movement disorders, including TD. "
07/01/2012 - "Tetrabenazine (TBZ) is a monoamine storage inhibitor that was first introduced in the 1970s for the management of hyperkinetic movement disorders. "
|5.||Dystonia (Limb Dystonia)
06/01/2000 - "After three years of treatment for dystonia with tetrabenazine, a clear reduction in the frequency, intensity and duration of the crises was perceived. "
03/10/1996 - "One of the patients developed dystonia 24 hours after ingestion of 750 mg tetrabenazine in an attempt at suicide. "
03/01/1989 - "Mild improvement has occurred after 5 months' treatment with tetrabenazine despite the long duration of dystonia and the presence of secondary structural changes."
02/01/1986 - "Tetrabenazine and dystonia in primates."
12/01/2014 - "Both subjects showed marked improvement in myoclonus and mild-to-moderate improvement in dystonia with tetrabenazine. "
|4.||Clonidine (ST 155)
|7.||Dopamine Receptors (Dopamine Receptor)
|8.||Antipsychotic Agents (Antipsychotics)
|9.||Levodopa (L Dopa)
|10.||Botulinum Toxins (Botulinum Toxin)
|4.||Drug Therapy (Chemotherapy)